Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
University of Pennsylvania Aetna, Inc. |
---|---|
Information provided by: | University of Pennsylvania |
ClinicalTrials.gov Identifier: | NCT00622102 |
We are performing a research study to learn more about the control of an individual's blood thinning (anticoagulation) on warfarin. Individuals from an anticoagulation clinic are being asked to participate in order to see if a lottery which provides the opportunity to win money in combination with the use of the Med-eMonitor might be useful in helping patients to achieve better control of their anticoagulation therapy. Half of the participants will be enrolled in the lottery arm and the other half will be a control group who will receive the Med-eMonitor only.
Condition | Intervention |
---|---|
Atrial Fibrillation Deep Venous Thrombosis Dilated Cardiomyopathies |
Behavioral: Lottery arm (Lottery and Med-eMonitor) Behavioral: Non-Lottery (Med-eMonitor only) |
Study Type: | Interventional |
Study Design: | Health Services Research, Randomized, Single Blind (Investigator), Parallel Assignment |
Official Title: | Testing Strategies to Improving Warfarin Adherence |
Estimated Enrollment: | 100 |
Study Start Date: | December 2007 |
Estimated Study Completion Date: | September 2008 |
Estimated Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
50% of the consenting subjects will take part in the lottery and use the Med-eMonitor as a device to monitor adherence
|
Behavioral: Lottery arm (Lottery and Med-eMonitor)
Lottery and Med-eMonitor
|
2
50% of the consenting subjects will use only the Med-eMonitor as a device to monitor adherence
|
Behavioral: Non-Lottery (Med-eMonitor only)
Med-eMonitor only
|
Ages Eligible for Study: | 21 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Jane A Jaskowiak, B.S.N., R.N. | 215-898-2625 | janejask@mail.med.upenn.edu |
United States, Pennsylvania | |
Hospital of the University of Pennsylvania Anticoagulation Management Center | Recruiting |
Philadelphia, Pennsylvania, United States, 19104 | |
Principal Investigator: Kevin G Volpp, M.D., Ph.D. |
Principal Investigator: | Kevin G Volpp, M.D., Ph.D. | University of Pennsylvania |
Responsible Party: | University of Pennsylvania School of Medicine ( Stephen E. Kimmel, M.D., M.S.C.E. ) |
Study ID Numbers: | 806634 |
Study First Received: | January 15, 2008 |
Last Updated: | February 21, 2008 |
ClinicalTrials.gov Identifier: | NCT00622102 |
Health Authority: | United States: Institutional Review Board |
warfarin adherence Mechanical heart valves |
Heart Diseases Cardiomyopathy, Dilated Vascular Diseases Warfarin Cardiomyopathies Thrombosis Embolism and Thrombosis |
Embolism Venous Thrombosis Atrial Fibrillation Cardiomegaly Dilated cardiomyopathy Arrhythmias, Cardiac |
Anticoagulants Pathologic Processes Therapeutic Uses |
Hematologic Agents Cardiovascular Diseases Pharmacologic Actions |